ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY
|
Back to Search Results |
|
Catalog Number SCF10X25AGEN |
Device Problems
Use of Device Problem (1670); Appropriate Term/Code Not Available (3191)
|
Patient Problem
Patient Problem/Medical Problem (2688)
|
Event Date 07/27/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
Medwatch sent to fda on 8/20/2015.The event of inadequate tissue ingrowth is a physiological complication, and analysis of the device generally does not assist allergan in determining a probable cause for this event.The physician discarded the device when it was explanted, and it is no longer available for return.Therefore, allergan will not receive the device, and no analysis or testing will be done.Device labeling addresses the reported event of inadequate tissue ingrowth as follows: "seri surgical scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling." these events are being reported because medical intervention was required, although device-relatedness has not been established.
|
|
Event Description
|
Healthcare professional reported implantation of seri surgical scaffold on (b)(6) 2015 during revision to left side mastectomy reconstruction.On (b)(6) 2015, during a cosmetic revision procedure, the device was discovered to be "100% unincorporated" and removed.The healthcare professional believes insufficient vascularization in the patient tissue after the reconstruction may have contributed to the lack of device incorporation, and the unincorporated scaffold device may have contributed to rupture of the breast implant.Both devices were removed on (b)(6) 2015, and the explanted scaffold was discarded after removal.
|
|
Search Alerts/Recalls
|
|
|